✦ LIBER ✦

Clinical data packages of drug approval for neurological diseases in Japan

✍ Scribed by Sakushima, K.; Nakamura, H.; Hashizume, A.

Book ID: 123572499
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 56 KB
Volume: 333
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2013.07.2266

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characteriation of Clinical Data Package

Characteriation of Clinical Data Packages Using Foreign Data in New Drug Applications in Japan

✍ Tanaka, M; Nagata, T 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Pivotal studies of orphan drugs approved

Pivotal studies of orphan drugs approved for neurological diseases

✍ Jun Mitsumoto; E. Ray Dorsey; Christopher A. Beck; Karl Kieburtz; Robert C. Grig 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Representation of older patients in clin

Representation of older patients in clinical trials for drug approval in Japan

✍ Asahina, Yasuko; Sugano, H.; Sugiyama, E.; Uyama, Y. 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 144 KB

Availability of pharmacogenomics-based p

Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs

✍ Zineh, I; Gerhard, T; Aquilante, C L; Beitelshees, A L; Beasley, B N; Hartzema, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 73 KB

Characteristics of pharmacogenomics/biom

Characteristics of pharmacogenomics/biomarker-guided clinical trials for regulatory approval of anti-cancer drugs in Japan

✍ Ishiguro, Akihiro; Yagi, Satomi; Uyama, Yoshiaki 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 364 KB

Targeted Regulatory Writing Techniques:

Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics || Clinical trial procedures and approval processes in Japan

✍ Wood, Linda Fossati; Foote, MaryAnn 📂 Article 📅 2009 🏛 Birkhäuser Basel ⚖ 199 KB